Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease
- Correspondence to:
Dr N J Shaw, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK;
ben.shaw{at}lwh-tr.nwest.nhs.uk
- Accepted 19 February 2002
Abstract
In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
